Inflammasomes: Pandora’s box for sepsis
Vijay Kumar1,2 1Children’s Health Queensland Clinical Unit, School of Clinical Medicine, Faculty of Medicine, Mater Research, University of Queensland, Brisbane, Australia; 2School of Biomedical Sciences, Faculty of Medicine, University of Queensland, Brisbane, Australia Abstract: Sepsis w...
Guardado en:
Autor principal: | Kumar V |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/946d110ab5ce475dae06a9955dcf121b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Non-Coding RNAs: Master Regulators of Inflammasomes in Inflammatory Diseases
por: Wang W, et al.
Publicado: (2021) -
Spotlight on the NLRP3 inflammasome pathway
por: Groslambert M, et al.
Publicado: (2018) -
MiR-940 Serves as a Diagnostic Biomarker in Patients with Sepsis and Regulates Sepsis-Induced Inflammation and Myocardial Dysfunction
por: Zhang S, et al.
Publicado: (2021) -
New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease
por: Zhang J, et al.
Publicado: (2021) -
Combination of Glutamine and Ulinastatin Treatments Greatly Improves Sepsis Outcomes
por: Wang J, et al.
Publicado: (2020)